What type of cancer is the chemotherapy drug bevacizumab used to treat?
Bevac refers to bevacizumab injection, which can treat various cancers including colorectal cancer, lung cancer, breast cancer, renal cell carcinoma, and brain gliomas. Detailed analysis is as follows:
1. Colorectal Cancer: Bevacizumab injection is used in the treatment of colorectal cancer, particularly metastatic colorectal cancer. The drug can be combined with chemotherapy agents for first-line or second-line therapy to help patients recover.
2. Lung Cancer: Bevacizumab injection is also indicated for non-small cell lung cancer (NSCLC). It can be used in combination with chemotherapy as first-line treatment for advanced or metastatic NSCLC, and as second-line treatment for recurrent or metastatic NSCLC.
3. Breast Cancer: Bevacizumab injection can be combined with chemotherapy as first-line treatment for metastatic breast cancer, and as second-line treatment for HER2-negative metastatic breast cancer.
4. Renal Cell Carcinoma: It can be used in combination with immunotherapeutic agents as first-line treatment for advanced or metastatic renal cell carcinoma.
5. Brain Glioma: Bevacizumab injection can be used to treat malignant brain gliomas such as glioblastoma. It may be combined with radiotherapy and chemotherapy for the treatment of recurrent or metastatic brain gliomas.
It should be noted that bevacizumab injection is typically used as an adjunctive therapy, administered in combination with other chemotherapy drugs or radiotherapy to enhance treatment efficacy. The specific treatment regimen should be determined by a physician based on the individual patient's condition.